Stock code: 688185 Stock abbreviation: CanSino Announcement No.: 2024-048

CanSino Biologics Co., Ltd

Announcement on the convening of the third quarter 2024 results briefing

The Board of Directors and all directors of the Company guarantee that there are no false records, misleading statements or material omissions in the content of this announcement, and assume individual and joint responsibility for the authenticity, accuracy and completeness of its content.

Important Content Notes:

The briefing session will be held from 15:00 to 16:00 on Monday, November 25, 2024

Explanation of the meeting venue: Shanghai Stock Exchange Roadshow Center

(Website: http://roadshow.sseinfo.com)

Explain the way the meeting was held: network interaction of the SSE Roadshow Center

Investors can register from 16:00 from Monday, November 18, 2024 to Friday, November 22, 2024

On the homepage of the website of the SSE Roadshow Center, click on the "Pre-solicitation of Questions" column or ask questions through the company's investor relations email (ir@cansinotech.com). The company will answer the questions of general concern to investors at the briefing.

CanSino Biologics Co., Ltd. (hereinafter referred to as the "Company") has released 2024 on October 30, 2024

The third quarter report of the year, in order to facilitate investors to have a more comprehensive and in-depth understanding of the company's operating results and financial status,

The company plans to hold the third quarter of 2024 business on November 25, 2024 (Monday) 15:00-16:00

Performance briefings to exchange views on issues of concern to investors.

1. Types of briefings

The investor briefing will be held in the form of online interaction, and the company will interact and communicate with investors on the specific situation of operating results and financial indicators in the third quarter of 2024, and answer questions of general concern to investors within the scope of information disclosure.

2. The time and place of the briefing

(1) Meeting time: 15:00-16:00 on November 25, 2024 (Monday).

(2) Venue: SSE Roadshow Center

(3) Convening method: network interaction of SSE Roadshow Center

3. Participants

Mr. XUEFENGYU, Chairman and General Manager of the Company, Mr. Cui Jin, Secretary of the Board of Directors, and Mr. Liu Ming, Acting Financial Director (if there are special circumstances, the participants may be adjusted).

IV. Investor Participation

(1) Investors can do so from 15:00 to 16:00 on November 25, 2024 (Monday) via the Internet

Log in to the SSE Roadshow Center (http://roadshow.sseinfo.com) to participate in the performance briefing online, and the company will answer investors' questions in a timely manner.

(2) Investors can apply from 18 November 2024 (Monday) to 22 November 2024 (Friday)

Log in to the SSE roadshow website before 16:00 and click on the "Ask a Pre-Solicitation Campaign" column

(http://roadshow.sseinfo.com/questionCollection.do), according to the time of the event, select this event or ask questions to the company through the company's investor relations email (ir@cansinotech.com), and the company will answer the questions of general concern to investors at the briefing.

5. Contact person and consultation method

Contact: Office of the Board of Directors

Phone: 022-58213766

Email: ir@cansinotech.com

6. Other matters

After the investor briefing meeting, investors can go through the SSE Roadshow

(http://roadshow.sseinfo.com) Check the convening and main content of this investor briefing.

The announcement is hereby made.

Board of Directors of CanSino Biologics Co., Ltd

November 16, 2024